Genmab A/S (OTCMKTS:GNMSF) Stock Price Crosses Above 50-Day Moving Average – Here’s Why

Shares of Genmab A/S (OTCMKTS:GNMSF) crossed above its 50 day moving average during trading on Tuesday . The stock has a 50 day moving average of $195.28 and traded as high as $202.90. Genmab A/S shares last traded at $199.35, with a volume of 139 shares trading hands.

Genmab A/S Stock Up 5.6%

The firm has a market capitalization of $13.17 billion, a PE ratio of 11.38 and a beta of 1.02. The company’s 50-day simple moving average is $195.31 and its 200 day simple moving average is $206.14.

Genmab A/S (OTCMKTS:GNMSF) last announced its earnings results on Thursday, May 8th. The company reported $3.05 earnings per share for the quarter, topping the consensus estimate of $1.88 by $1.17. The firm had revenue of $765.14 million for the quarter, compared to the consensus estimate of $761.09 million. Genmab A/S had a return on equity of 19.75% and a net margin of 36.30%.

About Genmab A/S

Genmab A/S develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. The company markets DARZALEX, a human monoclonal antibody for the treatment of patients with multiple myeloma (MM); teprotumumab for the treatment of thyroid eye disease; and Amivantamab for advanced or metastatic gastric or esophageal cancer and NSCLC.